What this study adds ?
The use of generic imatinib is widely prevalent throughout the globe,
although its efficacy and tolerability is still debated.To the best of
our knowledge this is the first trial on treatment free remission in
patients on generic imatinib.
Conflict of Interest : All authors declare that there is no
conflict of interest.
Ethics approval : All procedures performed in studies involving
human participants were in accordance with the ethical standards of the
institutional and/or national research committee and with the 1964
Helsinki declaration and its later amendments or comparable ethical
standards. Ethics approval was sought from the institute ethics
committee
Informed consent : Informed consent was obtained from all
individual participants included in the study.
Principal Investigator Statement : The authors confirm that the
Principal Investigator for this paper is Deepak Goni and he had direct
clinical responsibility for patients.
Author Contributions : DG and RN conducted the study,NJ did the
statistical analysis,PM,DL,AK,GP and AJ planned the study and drafted
the final manuscript,NV and SN provided the laboratory support.